Minimized extracorporeal circulation

From WikiMD's Medical Encyclopedia

Revision as of 22:53, 10 February 2025 by Prab (talk | contribs) (CSV import)

Minimized extracorporeal circulation (MECC) is a cardiopulmonary bypass technique used in cardiac surgery. It is a modified form of conventional extracorporeal circulation (ECC), designed to reduce the negative effects associated with conventional ECC.

History

The concept of minimized extracorporeal circulation was first introduced in the late 1990s. The aim was to develop a system that could reduce the negative effects of conventional extracorporeal circulation while maintaining the benefits of cardiopulmonary bypass.

Technique

The MECC system is a closed, sterile circuit that minimizes the contact between the patient's blood and the artificial surfaces of the extracorporeal circuit. This is achieved by reducing the priming volume, eliminating the cardiotomy suction, and using biocompatible coated circuits. The system also includes a centrifugal pump and a membrane oxygenator.

Advantages

The main advantages of MECC over conventional ECC include reduced systemic inflammatory response, less postoperative bleeding, and a lower requirement for blood transfusions. It also reduces the risk of organ damage and postoperative complications.

Disadvantages

Despite its advantages, MECC is not suitable for all types of cardiac surgery. It is not recommended for complex procedures that require a long duration of cardiopulmonary bypass.

Clinical significance

Several studies have shown that MECC can reduce the incidence of postoperative complications and improve patient outcomes in cardiac surgery. However, further research is needed to confirm these findings and to determine the optimal use of MECC in different types of cardiac surgery.

See also


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.